The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, welcomed a delegation of approximately 40 representatives from American medical companies today at the Authority's headquarters in Riyadh. Discussions centered on exploring investment opportunities within Saudi Arabia's healthcare sector.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, today launched an Artificial Intelligence Laboratory (SAIL) at the LEAP 2025 conference. The laboratory will serve as a specialized center for the development and implementation of artificial intelligence technologies, aimed at enhancing innovation and optimizing regulatory and operational processes within the SFDA.
The Saudi Food and Drug Authority (SFDA) has achieved a significant milestone by securing a spot among the top 10 government entities in the third round of the 2025 Emerging Technologies Readiness Index. This recognition, awarded for the second consecutive year, evaluates how well government entities adopt emerging technologies to enhance operational efficiency and achieve strategic advantages.
The Saudi Food and Drug Authority (SFDA) is participating in the LEAP 2025 Tech Conference, held under the slogan "Into New Worlds". The SFDA aims to showcase the latest smart technologies and digital solutions that enhance product safety, ensure the availability of medicines, and raise awareness of the Authority's areas of work.
H.E. Dr. Hisham S. Aljadhey, Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), today welcomed H.E. Cham Nimul, Cambodian Minister of Commerce, and her delegation to the SFDA headquarters in Riyadh. H.E. UK Sarun, Non-Resident Ambassador of Cambodia to Saudi Arabia, also attended the meeting.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, contributed his insights to a prominent panel discussion on “Regulatory Pathways: Balancing Innovation and Safety” at the Global Healthspan Summit 2025 in Riyadh on Tuesday. The session centered on the pivotal role of regulatory frameworks in fostering innovation while ensuring public safety, particularly in efforts to extend healthy lifespans.
Thuwal, Saudi Arabia, January 26, 2025 - The Saudi Food and Drug Authority (SFDA) and the Center of Excellence for Smart Health (KCSH) at King Abdullah University of Science and Technology (KAUST) hosted a workshop today, uniting prominent researchers, scientists, and officials to discuss the regulation and innovation of medical devices utilizing artificial intelligence (AI) and biotechnology.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, conducted an inspection visit to several facilities in Jeddah, including the Authority's branch office in the Western Region. This visit aimed to monitor operational progress and ensure the effectiveness of services to safeguard product safety. It is part of a series of routine tours across the Kingdom of Saudi Arabia to enhance oversight of products under the SFDA's jurisdiction.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, met with several company officials and representatives from the food, drug, medical devices, and medical products sectors in the Western Region. The meeting was held today, Monday, at the headquarters of the Jeddah Chamber of Commerce Industry (JCCI) and was attended by Mr. Mohammed Yousuf Naghi, the Chairman of the Board of Directors of JCCI.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, launched a new employee shuttle service today that utilizes the Riyadh Metro. The service will transport employees via buses to and from the main SFDA building and the King Abdullah Financial District (KAFD) Metro station.
